Clinical Trial

An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)

Name: An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315) — clinical trial record (NCT07744113)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Available

View on ClinicalTrials.gov →

Summary

To provide continued access to OLZ/SAM for pediatric participants with schizophrenia or bipolar I disorder who have completed participation in the ALKS 3831-A313 long-term safety extension study.

Trial Details

NCT Number	NCT07744113
Lead Sponsor	Alkermes, Inc.
Conditions	Bipolar 1 Disorder, Schizophrenia Disorder
Updated on ClinicalTrials.gov	2026-08-04